ScreenerHero
ERFEurofins Scientific SE
EPA · FR · Healthcare · Diagnostics & Research · eurofins.com
72.50EUR-0.47%Mkt Cap: 13.65B $P/E: 25.29

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and huma…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap13.65B $
Enterprise Value17.96B $
Revenue (TTM)8.03B $
Gross Profit5.40B $
Net Income (TTM)516.09M $
Revenue/Share45.48 USD
Last Price72.50 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees65.0K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)25.29
P/E (Forward)15.50
PEG1.03
EV/EBITDA10.75
EV/Revenue2.24
P/S1.70
P/B3.49
EPS (TTM)2.88
EPS (Forward)4.70
52W Range
54.8691% of range74.32
52W High74.32 EUR
52W Low54.86 EUR
Profitability
Gross Margin68.12%
Oper. Margin16.17%
EBITDA Margin20.81%
Profit Margin6.51%
ROE10.45%
ROA4.32%
Growth
Revenue Growth2.50%
Earnings Growth28.40%
Cash Flow & Leverage
Operating CF1.52B $
CapEx (TTM)907.39M $
FCF Margin4.60%
FCF Yield2.70%
Net Debt4.19B $
Net Debt/EBITDA2.51
Balance Sheet
Debt/Equity0.98
Current Ratio1.13
Quick Ratio0.87
Book Value/Sh20.85 EUR
Cash/Share3.559 EUR
Dividends
Fwd Div Rate0.7200 EUR
Trail. Div Rate0.7200 EUR
Div. Yield1.02%
5Y Avg Yield1.22%
Payout Ratio25.00%
Ex-Div DateApr 28, 2026
Pay Date—
Splits
Last Split10:1
Split DateNov 19, 2020
Analyst Consensus
Rating2.5 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)72.53 EUR
Upside (mean)+0.0%
Target Range58.00 EUR – 86.00 EUR
€58.00+0.0% to mean€86.00
# Analysts14
Ownership
Shares Out.172.37M
Float110.07M
Insiders36.50%
Institutions34.18%
Technical
SMA 5068.00 (+6.6%)
SMA 20064.71 (+12.0%)
Beta0.84
S&P 52W Chg18.16%
Avg Vol (30d)100.06K
Avg Vol (10d)170.91K
Technical Indicators
RSI (14)68.6
MACD0.8395
MACD Signal0.6670
MACD Hist.+0.1724
BB Upper72.15 EUR
BB Middle69.30 EUR
BB Lower66.45 EUR
BB Width8.22%
ATR (14)1.428 EUR
Vol Ratio (20d)1.39x